IS THERE ANY PLACE LEFT FOR OMEGA-3 FATTY ACIDS IN CARDIAC SURGERY?
https://doi.org/10.21292/2078-5658-2017-14-3-51-57
Abstract
Goal of the review: to study theoretical and applied aspects of using omega-3 fatty acids in the high risk patients undergoing cardiac surgery in order to reduce the intensity of system inflammatory response, caused by cardiopulmonary bypass and forming the basis of organ dysfunctions in the post-operative period.
About the Authors
V. V. Lomivorotov
E. N. Meshalkin Research Institute of Blood Circulation Pathology, Novosibirsk
Russian Federation
Correspondent Member of RAS, Doctor of Medical Sciences, Professor, Deputy Director for Research, Head of Anesthesiology and Intensive Care Center
Russian Federation
Correspondent Member of RAS, Doctor of Medical Sciences, Professor, Deputy Director for Research, Head of Anesthesiology and Intensive Care Center
S. M. Efremov
E. N. Meshalkin Research Institute of Blood Circulation Pathology, Novosibirsk
Russian Federation
Doctor of Medical Sciences, Anesthesiologist and Intensive Care Physician of Anesthesiology and Intensive Care Department
Russian Federation
Doctor of Medical Sciences, Anesthesiologist and Intensive Care Physician of Anesthesiology and Intensive Care Department
M. N. Abubakirov
E. N. Meshalkin Research Institute of Blood Circulation Pathology, Novosibirsk
Russian Federation
Anesthesiologist and Intensive Care Physician of Anesthesiology and Intensive Care Department
Russian Federation
Anesthesiologist and Intensive Care Physician of Anesthesiology and Intensive Care Department
Christian Stoppe
Clinic of RWTH Aachen University
Germany
Privat-Docent, Doctor of Medical Sciences, Consultant of Intensive Care Department
Germany
Privat-Docent, Doctor of Medical Sciences, Consultant of Intensive Care Department
References
1. Efremov S.M., Pokushalov E.А., Romanov А.B. et al. Investigation of antiarrythmic effect of polyunsaturated fatty acids in cardiac surgery. Data of implanted monitor of cardiac rhythm. Patologiya Krovoobrascheniya i Kardiokhirurgiya, 2014, vol. 18, no. 3, pp. 12-18. (In Russ.)
2. Filippovskaya Zh.S., Gerasimenko O.N., Grebenchikov O.А. et al. Oxidative stress and early post-operative complications in cardiac surgery. Messenger of Anesthesiology and Resuscitation, 2016, vol. 13, no. 6, pp. 13-21. (In Russ.)
3. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutrition, 2006, vol. 83, (6 suppl.), pp. 1467S−1476S.
4. Bang H.O., Dyerberg J., Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med. Scandinavica, 1976, vol. 200, no. 1-2, pp. 69-73.
5. Bays H.E. Safety considerations with omega-3 fatty acid therapy. Am. J. Cardiol., 2007, vol. 99, pp. 35-43.
6. Benjamin E.J., Blaha M.J., Chiuve S.E. On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation, doi: 10.1161/CIR.0000000000000485
7. Calò L., Bianconi L., Colivicchi F. et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J. Am. Coll Cardiol., 2005, vol. 17, no. 45, pp. 1723-1728.
8. Carpentier Y.A., Dupont I.E. Advances in intravenous lipid emulsions. World J. Surg., 2000, vol. 24, pp. 1493-1497.
9. Charman A., Muriithi E.W., Milne E. et al. Fish oil before cardiac surgery: neutrophil activation is unaffected but myocardial damage is moderated. Prostaglandins Leukot Essent Fatty Acids. 2005, vol. 72, no. 4, pp. 257-265.
10. Daren K.H., Lukan J.K., McClave S.A. The role of nutritional support in sepsis. Springer US, The Sepsis Text. 2002, pp. 479−490, ISBN 978-0-306-47664-8.
11. Duvall M.G., Levy B.D. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur. J. Pharmacol., 2016, vol. 15, no. 785, pp. 144-155.
12. Friedman A., Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin. J. Am. Society Nephrology, 2006, vol. 1, pp. 182-192.
13. Harris W.S. Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am. J. Cardiol., 2007, vol. 19, no. 99, pp. 44C−46C.
14. Kantarci A., Van Dyke T.E. Lipoxins in chronic inflammation. Critical reviews in oral biology and medicine: an official publication of the American Association of Oral Biologists. 2003, vol. 14, no. 1, pp. 4.
15. Klek S., Kulig J., Sierzega M. et al. The impact of immunostimulating nutrition on infectious complications after upper gastrointestinal surgery: a prospective, randomized, clinical trial. Ann. Surgery, 2008, vol. 248, no. 2, pp. 212-220.
16. Kloner R.A., Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation, 2001, vol. 104, no. 24, pp. 2981-2989.
17. Koster S., Oosterveld F.G., Hensens A.G. et al. Delirium after cardiac surgery and predictive validity of a risk checklist. Ann. Thoracic Surgery, 2008, vol. 86, no. 6, pp. 1883-1887.
18. Laffey J.G., Boylan J.F., Cheng D.C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology, 2002, vol. 97, no. 1, pp. 215-252.
19. Li X.L., Steiner M. Fish oil: a potent inhibitor of platelet adhesiveness. Blood, 1990, vol. 76, pp. 938-945.
20. Marchioli R., Barzi F., Bomba E. et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation, 2002, vol. 105, pp. 1897-1903.
21. Mariani J., Doval H.C., Nul D. et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. J. Am. Heart Association, 2013, vol. 2, no. 1, e005033.
22. Manzanares W., Langlois P.L., Dhaliwal R. et al. Intravenous fish oil lipid emulsions in critically ill patients: an updated systematic review and meta-analysis. Crit. Care, 2015, vol. 19, pp. 167.
23. Mayer K., Gokorsch S., Fegbeutel C. et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am. J. Respire. Crit. Care Med., 2003, vol. 167, no. 10, pp. 1321-1328.
24. McGowan F.X., Ikegami M., Nido P.J. et al. Cardiopulmonary bypass significantly reduces surfactant activity in children. J. Thorac. Cardiovasc. Surg., vol. 106, no. 1993, pp. 968-977.
25. Montgomery P., Richardson A.J. Omega-3 fatty acids for bipolar disorder. Cochrane database of systematic reviews, 2008, vol. 2, CD005169.
26. Mozaffarian D., Marchioli R., Gardner T. et al. The ω-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) trial-rationale and design. Am. Heart J., 2011, vol. 162, no. 1, pp. 56-63.
27. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. College Cardiology, 2011, vol. 58, no. 20, pp. 2047-2067.
28. Ott J., Hiesgen C., Mayer K. Lipids in critical care medicine. Prostaglandins, leukotrienes, and essential fatty acids. 2011, vol. 85, no. 5, pp. 267-273.
29. Ovize M., Baxter G.F., Di Lisa F. et al. Postconditioning and protection from reperfusion injury: where do we stand? Cardiovasc. Res., 2010, vol. 87, pp. 406-423.
30. Parish M., Valiyi F., Hamishehkar H. et al. The effect of Omega-3 fatty acids on ARDS: A Randomized Double-Blind Study. Advanced Pharmaceutical Bulletin, 2014, vol. 4, suppl. 2, pp. 555-561.
31. Pascal L., Langlois G.H., Manzanares W. ω-3 polyunsaturated fatty acids in cardiac surgery patients. J. Parenteral and Enteral Nutrition, vol. 41, issue 2, pp. 152-154.
32. Pennock J., Pierce W., Waldhausen J. The management of the lungs during cardiopulmonary bypass. Surg. Gynecol Obstet., 1977, vol. 145, pp. 917-927.
33. Pontes-Arruda A., Martins L.F., de Lima S.M. et al. Investigating nutritional therapy with EPA, GLA and antioxidants role in sepsis treatment (INTERSEPT) Study Group. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit. Care, 2011, vol. 9, no. 15, pp. R144.
34. Plourde M., Cunnane S.C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Applied Physiology, Nutrition, and Metabolism. Physiologie Appliquee, Nutrition et Metabolisme, 2007, vol. 32, no. 4, pp. 619-634.
35. Rees A.M., Austin M.P., Parker G.B. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. The Austral. New Zealand J. Psychiatry, 2008, vol. 42, no. 3, pp. 199-205.
36. Richard C.B., Smith J.E., Yeh Yu-Yan. The effects of dietary fish oil on alveolar type II cell fatty acids and lung surfactant phospholipids. Lipids March, 1993, vol. 28, is. 3. pp. 167-172.
37. Rizos E.C., Ntzani E.E., Bika E. et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA, 2012, vol. 308, no. 10, pp. 1024-1033.
38. Roulet M., Frascarolo P., Pilet M. et al. Effects of intravenously infused fish oil on platelet fatty acid phospholipid composition and on platelet function in postoperative trauma. JPEN J. Parenteral Enteral Nutrition, 1997, vol. 21, no. 5, pp. 296-301.
39. Serhan C.N., Brain S.D., Buckley C.D. et al. Resolution of inflammation: state of the art, definitions and terms. FASEB Journal: official publication of the Federation of American Societies for Experimental Biology, 2007, vol. 21, no. 2, pp. 325-332.
40. Simoens C.M., Deckelbaum R.J., Massaut J.J. et al. Inclusion of 10% fish oil in mixed medium-chain triacylglycerol-long-chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids. Am. J. Clin. Nutrition, 2008, vol. 88, no. 2, pp. 282-288.
41. Suleiman M.S., Zacharowski K., Angelini G.D. Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics. British J. Pharmacology, 2008, vol. 153, no. 1, pp. 21-33.
42. Tsekos E., Reuter C., Stehle P. et al. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin. Nutrition, 2004, vol. 23, no. 3, pp. 325-330.
43. Thomas C.H., Dilraj K.B., Dhya Al-Leswas et al. A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically ill patients with sepsis. J. Parenteral and Enteral Nutrition, vol. 39, issue 3, pp. 301-312.
44. Wanten G.J., Calder P.C. Immune modulation by parenteral lipid emulsions. Am. J. Clin. Nutrition, 2007, vol. 85, no. 5, pp. 1171-1184.
45. Yang G., Xue X., Chen Y. et al. Effects of cardiopulmonary bypass on lung nuclear factor-kappa B activity, cytokine release, and pulmonary function in dogs. Iranian J. Basic Med. Sciences, 2015, vol. 18, no. 12, pp. 1233-1242.
Review
For citations:
Lomivorotov V.V., Efremov S.M., Abubakirov M.N., Stoppe Ch. IS THERE ANY PLACE LEFT FOR OMEGA-3 FATTY ACIDS IN CARDIAC SURGERY? Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2017;14(3):51-57. (In Russ.) https://doi.org/10.21292/2078-5658-2017-14-3-51-57
Email this article 